33.000
+0,00%
2026-10-15
Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +289.8% | +130.1% | 3 / 3 | +10.9% | +1.85 pp | +23.75 pp | +13.7% | 0.35 | 9.56 | 958 | +10,9% | 316 | +294,6% | 9.56 | 19.74 | −51,6% |
| Pts | 12 | 12 | 12 | 4 | 8 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 33.000 (close price on 2026-10-15)EPS (TTM): 3.452
Financial charts
1.Revenue & growth
VND bn958Q2/26
1.Revenue & growth
VND bn958Q2/26
2.Profit & growth
VND bn299Q2/26
3.Profit mix (Penman)
VND bn730Q2/26
4.Margins & cost structure
%17.9%Q2/26
5.Returns & cash cycle
% · days4.8%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn8.836Q2/26
8.Funding & debt health
VND bn · times8.836Q2/26
9.Revenue backlog
VND bn7,03Q2/26
10.Valuation
times · %9,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.732Q2/26
Adjusted EPS growth, latest quarter
290%
Average adjusted EPS growth, 3 quarters
130%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26